Sue-Jane Wang, Ph.D. Associate Director Adaptive Design and Pharmacogenomics Office of Biostatistics, Office of Translational Sciences Center for Drug.
Emerging Trends in Regulatory Biostatistics - What might be their impact ? Robert T. O’Neill Ph.D. Director, Office of Biostatistics Office of Translational.
"Developing statistically-valid and -defensible frameworks to assess status and trends of ecosystem condition at national scales" "Developing statistically-valid.
Using Tolerance Intervals for Setting Process Validation Acceptance Criteria Richard K. Burdick —Amgen, Inc. (CO) Graybill Conference June, 2008.
